U.S. Markets open in 2 hrs 11 mins

AstraZeneca PLC (AZN.L)

London Stock Exchange - London Stock Exchange Delayed Price. Currency in GBp
Add to watchlist
4,519.50+24.50 (+0.55%)
As of 12:04PM BST. Market open.
Full screen
Previous Close4,495.00
Open4,494.50
Bid4,519.00 x 6100
Ask4,519.50 x 13000
Day's Range4,491.50 - 4,527.50
52 Week Range3,996.00 - 5,520.00
Volume377,673
Avg. Volume2,120,084
Market Cap57.21B
Beta0.62
PE Ratio (TTM)16.93
EPS (TTM)267
Earnings DateNov 9, 2017
Dividend & Yield2.79 (4.97%)
Ex-Dividend Date2017-08-10
1y Target Est62.35
  • The Wall Street Journal2 days ago

    [$$] German Biotech Startup Ethris Strikes Respiratory Drug Deal With AstraZeneca

    AstraZeneca PLC is betting that technology from German startup Ethris GmbH will help it add to its stockpile of treatments for respiratory diseases.

  • MarketWatch3 days ago

    Champions Oncology shares surge 8% on news of AstraZeneca collaboration

    Champions Oncology Inc. shares surged 8.2% in premarket trade Monday on news of the company's collaboration with AstraZeneca . The companies plan to develop new Patient-Derived Xenograft (PDX) models -- ...

  • Barrons.com6 days ago

    Tesaro: Losing Its Edge?

    The FDA decided yesterday to expand the use of the ovarian cancer drug Lynparza, sold by AstraZeneca (AZN) and Merck (MRK). The two drugs belong to a class known as PARP inhibitors. Approved in 2014, AstraZeneca's Lynparza was the first such drug to make its way through the FDA.